Neuphoria Therapeutics Inc. Gains Losses On Exchange Differences On Translation Recognised In Profit Or Loss
Neuphoria Therapeutics Inc. (NEUP) reported Gains Losses On Exchange Differences On Translation Recognised In Profit Or Loss of AUD 1.80 million for the 12-month period ending 2022-06-30, per its 20-F filed 2022-10-14.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss · last filed 2022-10-14
| Period end | Gains Losses On Exchange Differences On Translation Recognised In Profit Or Loss 12 month |
|---|---|
| 2022-06-30 | 1.80M AUD 20-F · filed 2022-10-14 |
| 2021-06-30 | -222.68K AUD 20-F · filed 2022-10-14 |
| 2020-06-30 | -2.18M AUD 20-F · filed 2022-10-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |